.
Development of biomarkers and therapeutic drug monitoring as tool to personalize immunosuppresive therapy in kidney transplant recipients
Project/agreement No.
132101
Project funding
20 000.00 EUR
Project manager
Project realization
01.04.2019. - 31.03.2020.
Aim
The aim of the project is to develop biomarker-based kidney transplant evaluation tool to provide personalized immunosuppressive therapy prolonging the half-life of kidney transplants.
